Alloimmune thrombocytopenia

Clin Obstet Gynecol. 1999 Jun;42(2):335-48. doi: 10.1097/00003081-199906000-00018.

Abstract

For the fetuses who are at risk for antenatal or postnatal sequelae from AIT, prevention and treatment are now possible. This requires the attention of the obstetrician to factors in the patient's history and early referral to a center experienced in the diagnosis and management of fetal AIT.

Publication types

  • Review

MeSH terms

  • Antibodies / analysis
  • Antigens, Human Platelet / analysis
  • Blood Platelets / immunology
  • Cordocentesis
  • Fetal Diseases / diagnosis*
  • Fetal Diseases / immunology
  • Fetal Diseases / therapy*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant, Newborn
  • Thrombocytopenia / diagnosis*
  • Thrombocytopenia / immunology
  • Thrombocytopenia / therapy*

Substances

  • Antibodies
  • Antigens, Human Platelet
  • Immunoglobulins, Intravenous